Dr. Woloschak joined Soleno as Vice President Clinical Development in September 2021. He is an endocrinologist with over 24 years of experience in Clinical Development. Prior to joining Soleno, Dr. Woloschak worked for 7 years as Senior Medical Director at Sanofi Genzyme in areas of rare diseases and diabetes. He held previous positions of increasing responsibility at Hoffmann-La Roche and Novartis, supporting numerous development programs in diabetes and obesity. He received his medical degree from the Medical College of Ohio and completed residency and fellowship training at the University of Illinois Medical Center, Chicago and the National Institutes of Health, Bethesda. Through extensive post-doctoral training, he developed further expertise in molecular studies. Prior to joining industry, he served as Assistant Professor of Medicine at the Mount Sinai School of Medicine in New York where he obtained NIH funding to support his research on pituitary tumorigenesis and authored several peer-reviewed publications.
Developing novel therapeutics for the treatment of rare diseases.